The role of CD47—often expressed on tumor cells—as a 'don't eat me' signal that inhibits macrophage phagocytosis is well established. But new work reveals a major role for other immune cell types—T cells and dendritic cells—in the anti-tumor effects of therapeutic CD47 blockade.
References
Grimsley, C. & Ravichandran, K.S. Trends Cell Biol. 13, 648–656 (2003).
McCracken, M.N., Cha, A.C. & Weissman, I.L. Clin. Cancer Res. 21, 3597–3601 (2015).
Willingham, S.B. et al. Proc. Natl. Acad. Sci. USA 109, 6662–6667 (2012).
Beatty, G.L. et al. Science 331, 1612–1616 (2011).
Ruffell, B. & Coussens, L.M. Cancer Cell 27, 462–472 (2015).
Liu, X. et al. Nat. Med. 21, 1209–1215 (2015).
Sharma, P. & Allison, J.P. Cell 161, 205–214 (2015).
Barrett, D.M., Singh, N., Porter, D.L., Grupp, S.A. & June, C.H. Annu. Rev. Med. 65, 333–347 (2014).
Tseng, D. et al. Proc. Natl. Acad. Sci. USA 110, 11103–11108 (2013).
Soto-Pantoja, D.R. et al. Cancer Res. 74, 6771–6783 (2014).
Vonderheide, R.H. & Glennie, M.J. Clin. Cancer Res. 19, 1035–1043 (2013).
Lesokhin, A.M., Callahan, M.K., Postow, M.A. & Wolchok, J.D. Sci. Transl. Med. 7, 280sr281 (2015).
Acknowledgements
This work was supported by US National Institutes of Health grant R01 CA169123.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Vonderheide, R. CD47 blockade as another immune checkpoint therapy for cancer. Nat Med 21, 1122–1123 (2015). https://doi.org/10.1038/nm.3965
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3965
- Springer Nature America, Inc.
This article is cited by
-
A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade
Journal of Cancer Research and Clinical Oncology (2023)
-
Targeting macrophages in hematological malignancies: recent advances and future directions
Journal of Hematology & Oncology (2022)
-
Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy
Nature Nanotechnology (2022)
-
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
Cancer Immunology, Immunotherapy (2022)
-
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides
Cancer Immunology, Immunotherapy (2022)